We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
94 hedge funds and large institutions have $74.5M invested in Invesco Pharmaceuticals ETF in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
11% more capital invested
Capital invested by funds: $66.9M → $74.5M (+$7.56M)
4% more funds holding
Funds holding: 90 → 94 (+4)
1.32% less ownership
Funds ownership: 18.19% → 16.87% (-1.3%)
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
28
Reduced
22
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.72M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.88M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.03M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$906K |
| 5 |
Morgan Stanley
New York
|
+$853K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.53M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.39M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$696K |
| 4 |
Citigroup
New York
|
-$534K |
| 5 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$400K |
